The Discounted Cash Flow (DCF) valuation of Health Catalyst Inc (HCAT) is (30.48) USD. With the latest stock price at 2.71 USD, the upside of Health Catalyst Inc based on DCF is -1224.7%.
Based on the latest price of 2.71 USD and our DCF valuation, Health Catalyst Inc (HCAT) is a sell. selling HCAT stocks now will result in a potential gain of 1224.7%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 4.5% - 8.6% | 6.6% |
| Long-term Growth Rate | 3.0% - 4.3% | 3.6% |
| Fair Price | (329.09) - (17.16) | (30.48) |
| Upside | -12243.7% - -733.1% | -1224.7% |